Searchable abstracts of presentations at key conferences in endocrinology

ea0090p20 | Adrenal and Cardiovascular Endocrinology | ECE2023

Reduction of albuminuria after surgical and medical treatment of primary aldosteronism

Sng Gerald , Zhang Meifen , Puar Troy

Introduction: Primary aldosteronism (PA) is a common cause of secondary hypertension that can lead to renal sequelae. Treatment of hyperaldosteronism leads to reductions in albuminuria and glomerular hyperfiltration. We aimed to evaluate the effect of treatment on albuminuria and temporal changes in renal function after treatment with both surgery and medications.Methods: We prospectively recruited patients with PA over three years. Spot urine samples fo...

ea0049ep24 | Adrenal cortex (to include Cushing's) | ECE2017

Are we missing patients with primary aldosteronism (PA) if we require both elevated aldosterone: renin ratio (ARR) and elevated aldosterone levels?

Puar Troy , Khoo Joan , Zhang Meifen

Introduction: Although the Endocrine Society guidelines recommend using aldosterone: renin ratio (ARR) to screen patients for primary aldosteronism (PA), whether to include a cut-off for aldosterone levels remains controversial. In Singapore, most centres require both an ARR >550 (ng/dl)/(ng/ml per h) and aldosterone ≥15 ng/dl. However, it has been shown that patients with PA may have aldosterone levels<15 ng/dl, and also respond well to mineralocorticoid antagon...

ea0032p673 | Male reproduction | ECE2013

The role of testosterone augmentation in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) in improving functional recovery and hospital stay

H K Puar Troy , Tud Richard Chen Yuan

Introduction: Low testosterone levels are found in up to 50% of male patients with chronic obstructive pulmonary disease (COPD), and acute illness is associated with further suppression of the central and peripheral gonadal axis. Testosterone supplementation in chronic stable COPD patients has yielded mixed results, demonstrating increased lean body mass, and improved exercise capacity in some studies, but not others. Use of anabolic steroids during acute illness has shown ben...

ea0056p30 | Adrenal cortex (to include Cushing's) | ECE2018

Assessing the new Primary Aldosteronism guidelines recommendation to omit confirmatory testing in selected patients – severity of hypokalaemia may be included

Tan Sarah , Zhang Meifen , Khoo Joan , Puar Troy

Background: Patients with an elevated aldosterone renin ratio (ARR) should proceed for a confirmatory test to diagnose primary aldosteronism (PA) before undergoing further investigations such as CT imaging and adrenal venous sampling. The recent 2016 clinical guidelines have included a new recommendation: that in the setting of spontaneous hypokalaemia, undetectable plasma renin, and plasma aldosterone concentration (PAC) >20 ng/dl, patients may not require further confirm...

ea0063p445 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

11C-Metomidate PET/CT Identifies Unilateral Primary Aldosteronism in a Multi-ethnic Cohort

Puar Troy , Tan Colin , Tong Aaron , Zhang Meifen , Khoo Chin Meng , Tan Alvin , Htoo Htoo , Reilhac Anthonin , Weekes Ashley , Robins Ed , Foo Roger

Introduction: Patients with unilateral primary aldosteronism (PA) can be cured with adrenalectomy, and adrenal vein sampling (AVS) remains the gold-standard test. However, AVS is invasive, technically-challenging and criteria for determining lateralization differ between centres. 11C-Metomidate PET/CT (MTO) imaging offers a promising non-invasive alternative for identifying unilateral PA.Methods: All patients with confirmed primary aldosteronism who were...

ea0049gp160 | Neuroendocrinology &amp; Growth Hormones | ECE2017

Somatic mutations in USP8 are frequent events in pituitary tumors causing Nelson’s syndrome

Perez-Rivas Luis G , Theodoropoulou Marily , Puar Troy H , Fazel Julia , Stieg Mareike R , Ferrau Francesco , Assie Guillaume , Gadelha Monica R , Deutschbein Timo , Fragoso Maria C , Kusters Benno , Korbonits Marta , Bertherat Jerome , Stalla Gunter K , Hermus Ad R , Beuschlein Felix , Reincke Martin

Recent studies have reported a high prevalence of USP8 mutations in corticotroph adenomas causing Cushing’s disease. Nelson’s syndrome is a potentially life-threatening complication of bilateral adrenalectomy in patients with refractory Cushing’s disease that is caused by the development of an ACTH-secreting tumor in the pituitary gland. Whether USP8 alterations are also present in Nelson’s tumors has not been studied in detail so far....